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THE MECHANISM OF" SUPPRESSION OF SHOCK-INDUCED
FIGHTING BY CHLORDIAZEPOXIDE
LINDA F. QUENZER
Chlordiazepoxide (CDP), one of a number of drugs in' the
class Ijnown as the benzodiazepines, is known to have central
muscle relaxant effects , anticonvulsant effects against elec-
troconvulsive shock and chemical agents, depressive effects
on the duration of electrical afterdischarges in the limbic
system, and attenuation of fear in avoidance and conflict
situations • It also has been found to have a suppressive
effect on a number of aggressive behavioral responses. CDP
was found to depress mouse killing in rats (Loiselle and
Caparell, 1966), to have taming effects on vicious cynomolgus
monkeys (Heise and Boff, 1961), to produce calming of "septal
rats" (Horovitz, Furgiuele, Brannick, Burke and Craver, 1963);
to reduce shock-induced fighting of mice (Stille, 1962), and
to lessen fighting of previously isolated mice (Cole and Wolf,
1966). Reduction of aggressive behavior, then, would seem to
be quite evident
•
However, a problem arises when one asks whether suppres-
sion of aggressive behavior is due to an anti-aggressive
pharmacologic property of CDP or a secondary effect due to
general behavior depression. Evidence supporting the behav-
ioral depressive effect of CDP as the primary cause of re-
duced aggression is presented by Horovitz, Raggozzino and
Leaf (1965) and Horovitz, Piala, High, Burke, and Leaf (1966).
It was found that the dose of CDP that was effective in sup-
pressing mouse killing was approximately six times the dose
that effectively impaired rotarod1 performance. In order to
provide a fair measure of nonspecific depressant action, CDP
was also evaluated for its effects on a conditioned avoid-
ance response (pole climbing to avoid shock) and was found
again to have a depressant effect on the avoidance response
at a dose lower than that at which mouse killing was signifi-
cantly reduced.
A study by Gray, Osterberg and Rauh (1961) as cited in
Randall and Schallak (1968), supports the finding of Horovitz
and his coworkers (1965, 1966). They found that CDP did not
reduce isolation-induced fighting behavior of mice except at
doses more potent than that which caused ataxia.
Opposite results were reported in the previously cited
study of Loiselle and Capparell (1966) who found CDP signifi-
cantly decreased mouse killing by rats. They found that
significantly fewer CDP treated rats killed mice than rats
treated with chlorpromazine ; and a greater percentage of rats
in the no-drug control group killed mice than the chlorproma-
zine treated group. In order to determine the extent of gen-
eral behavioral depression, general activity level was
measured for each of the subjects in both an activity wheel
and a pivital "jiggle box". The group receiving CDP was
1. Rotarod is a slowly rotating rod upon which the animals
attempt to maintain balance.
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significantly more active than the chlorpromazine group, while
not differing significantly from the controls. It was con-
cluded, therefore, that CDP decreased mouse killing behavior
and that the anti-aggressive effect of the drug could not be
attributed to general depression of behavior.
Similar results were reported by Heise and Boff (1961)
who. devised a check list of behaviors in order to differenti-
ate between aggressive behaviors and more general activity.
Once the motor activity, ataxia, and response to auditory and
visual stimuli were examined, a ratio of the amount of activ-
ity was determined • "Tame" animals were designated as those
whose aggression-activity ratio was 0.5 or less, meaning that
activity was at least twice as frequent as aggressive behav-
iors. They found that "tame" animals were not significantly
less active. Behaviorally they were not sluggish or ataxic,
but did not attack when handled or poked. "Taming" was con-
firmed for animals receiving doses of 5 mg/kg p.o. chlordiaze-
poxide.
Stille (1962) found CDP blocked shock-induced fighting
in mice at a dose which did not impair the righting reflex.
It took approximately eight times the dose that suppressed
shock-induced fighting between paired mice to cause loss of
righting reflexes. The ratio between anti-fighting effect
and lethal dose was about 1:20. Thus, careful consideration
of the available data still leaves unanswered the question of
whether suppression of aggressive behavior is due to specific
pharmacologic anti-aggressive properties of CDP or is due to
general behavioral depression.
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The determination of the role of behavioral depression
as it relates to other drug effects has proved a formidable
task primarily because any behavioral test is confounded by
drug effects on motor coordination, response threshold to
stimuli of different motivational significance, and so on.
Perhaps the ideal method of determining the extent of behav-
ioral depression would be to assess the depression level in
terms of a neural correlate. Schallek and Kuehn (1965) demon-
strated a significant increase in the frequency of the spon-
taneous EEG in cats after a 10 mg/kg dose of CDP, but they
did not find a significant change in the threshold for behav-
ioral arousal with stimulation of the reticular formation
after administering CDP. However, when the more potent con-
gener, diazapam, was used the arousal threshold was elevated.
These results suggested to the authors, "that depression of
the cephalic outflow of the reticular, formation plays only a
minor role in the action of these drugs." The correlation
of the EEG recordings and threshold of arousal to the more
subjective evaluation of behavioral depression caused by
benzodiazepines has thus not been clearly determined.
While a neural correlate has not been determined, more
recently Wise, Berger, and Stein (1972) have determined a
neurochemical correlate of the depressive effect of the
benzodiazepines. Using oxazepam and the Geller-Seifter con-
flict test1 with rats they separated the behavioral depressive
and the anti-anxiety effects of the drug and found a
1. A leverpress produces an inescapable foot shock as well
as food reward.
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correlation with NE and 5HT turnover respectively in the mid-
brain-hindbrain region. Moreover, the depressant action in
the conflict test disappeared after six doses of oxazepam;
and similarly, the reduction in the turnover rate of NE
after six doses of oxazepam could no longer be detected,
»
This work, then, seems to establish rather conclusively that
tolerance to the depressive effect of the benzodiazepines
occurs with repeated testing, i.e., after five or six doses.
Thus, one way of eliminating the behavioral depressive
effect of CDP would be to allow drug tolerance of the effect
to develop during chronic administration of the drug.
Margules and Stein (1968) have already shown that the behav-
ioral depressant action of oxazepam, a drug in the benzodiaze-
pine class, on a VI schedule with food reinforcement, declined
over repeated doses and disappeared almost completely. How-
ever, another study was done which 'showed that CDP's behav-
ioral depressant effect did not diminish with repeated admin-
istration of the drug. Ralph (unpublished master's thesis)
showed that tolerance of behavioral depression on spontaneous
activity did not develop after repeated testing with a dose
of 15 mg/kg. Upon increasing the dose to 100 mg/kg he did
find some tolerance of the drug-induced depression of spon-
taneous activity. This result supported similar findings by
Goldberg, et al (1967). Hoogland, et al (1966) suggested
that tolerance in this case is a drug disposition tolerance;
that is, it is due to an increased rate of CDP disappearance
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from tissues and excretion of the drug from the body. This
increase involves a drug-induced stimulation of hepatic
microsomal enzymes found to be responsible for CDP metabolism.
If this hypothesis is valid, it could then be supposed that
15 mg/kg doses were not sufficient to stimulate the produc-
tion of the metabolic enzymes and therefore no tolerance
developed with that dose.
A second explanation for the discrepancy between the
results of Ralph, and those of Margules and Stein is that
motivational levels within the testing situation may deter-
mine whether tblerance effects will be detected. For example,
one could assume that exploratory behavior in the relatively
barren environmental space of an activity cage
,
comparative-
ly speaking, would not be very highly motivated. After a
15 mg/kg dose of CDP there was a significant suppression of
exploratory behavior (Ralph) • Even if some tolerance did
develop it is still possible that there was no observable
behavior change because the dose was sufficiently large to
obscure the gradual increase in general activity. On the
other hand, in Margules and Stein's procedure, because the
rats were food deprived they were probably motivated enough
to respond normally as soon as the depressive effects of the
drug were diminished.
In the present study anti-aggression properties of CDP
were sought using shock-induced fighting in rats as the behav-
ioral test. The possible identification of the anti-aggressive
pharmacologic properties of CDP immediately posed the problem
of isolating the effects of generalized behavioral depression.
First, the similarities and differences in the physical
features of the test for behavioral depression as compared
to the physical parameters of the anti-aggression test must
be considered. In the former studies that examined shock-
induced fighting the commonly used methods for determining
behavioral depression, such as the rotarod, inclined screen,
and activity cage, seem to be of questionable relevance in
evaluating the role of behavioral depression with respect to
fighting. Since tolerance has been shown to occur or not to
occur under different experimental conditions (Margules and
Stein, 1968; Ralph, 1969) it would seem reasonable to use a
tesing situation for .behavioral depression that is at least
similar in some respects to the shock-induced fighting para-
digm.
It would appear, then, that a shock assay method which
indicates the rat's response to various grid shock intensities
under drug and no drug conditions would be a preferred method
of testing behavioral depression in relation to the shock-
induced " fighting tests. Although this method appears to
have greater similarity not only to the physical parameters
but also to the motivational features of the shock-induced
fighting situation than any of the tests previously used,
there is, none the less, an important difference between
them. Recently, Williams and Eichelman, (1971) have shown
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that the physiological concomitants of the fear response
elicited in the shock assay test and those of the aggressive
response elicited in the fighting test are distinctly differ-
ent • Measuring blood pressure using a tail cuff, they found
blood pressure elevation during the jump-flinch test while
the pressure showed a significant drop during the fighting
test. This difference in blood pressure change suggests that
the underlying physiological responses may be significantly
different. It is quite clear that although the shock assay
test best approximates a number of parameters of the fighting
test, direct comparison of the two is of questionable valid-
ity.
On the other hand, the jump-flinch test is useful in
demonstrating the time course of tolerance of behavioral de-
pression over several days and might also be an effective
way of determining the extent of acute tolerance that may
build up within a single day of testing. Also this paradigm
represents a technique that possibly permits the detection
of the interaction of levels of motivation and the develop-
ment and detection of tolerance.
2. the jump-flinch test measures the degree to which a rat
responds to increasing levels of grid shock.
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EXPERIMENT la.
The effect of CDP on the jump-flinch test.
In this test the effect of repeated administration of
CDP on responding to varying levels of foot shock was deter-
mined.
METHOD
Subj ects
The subjects were 30 Charles River, Sprague-Dawley strain,
male albino rats, between 90 and 120 days old at the start of
the procedures.
Apparatus
The apparatus was a Grason-Stadler rat test chamber, 29
x 23 x 9 cm. The grid floor of the box was wired to a Grason-
Stadler shock source, model E1064GS and scrambler unit. A
Plexiglas door gave the experimenter a clear view of the ani-
mais • The experimenter sat quietly 3 to 4 feet from the win-
dow and recorded responses to the shock. The ventilating fan
for the test chamber also served to mask the sound of the
programming apparatus
.
Procedure
The subjects were randomly divided into two groups, one
receiving 15 mg/kg ,i.p. CDP 30 minutes before each test session
and a second which received no drug. Each subject ivas placed
in the test chamber and allowed to explore freely for a few
minutes. When the rat stopped excessive exploratory behavior
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the test session was started by administering a series of 19
1-second foot shocks of varying intensities (see below) and
recording the rat's response. The response was evaluated on
a three point scale, A zero (0) was recorded for the trials
in which the animal made no noticeable response to the shock.
An evaluation of "1" was made if the rat raised only one paw
from the grid or noticeably flinched without -raising a paw.
A designation of "2 11 corresponded to the movement of two or
more paws by the rat from the grid floor.
The footshocks varied in intensity from .025 to .475 mA.
with step intervals of approximately .02 5 mA. between each
intensity. A pilot study had shown that this range provides
sufficient diversity in shock intensities to elicit the com-
plete range of responses in most rats. The duration of the
shock was 1 second • The interval between shocks was variable
and was regulated by the experimenter in order to allow time
for the animal to stop moving after the previous shock stimu-
lus . However, a timing device provided a minimum intertrial
interval of 5 seconds by opening the recording circuit. The
nineteen shocks were administered in a fixed random order and
constituted one series. Each rat received 10 consecutive
series for 5 consecutive days. The rats returned to their
individual living cages immediately after testing. Their
daily ration of food (lab chow) was then given. Water was al-
ways available except in the test chamber.
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Results
An analysis of variance for Within and Between subjects'
effects was performed on the data for Experiment la, the jump-
flinch test. The results are shown in Table 1. With respect
to the main effect of Shock Level the analysis showed a high-
ly significant effect (p(.001), indicating that the Ss respond-
ed differently at different shock levels. This is clearly
shown in Fig. 1 which reveals a higher mean value of responses
as shock intensity increases. The Groups main effect was also
clearly significant (p<.01), indicating a difference in re-
sponding to the various levels of foot shock for the Drug and
No-drug groups. A comparison of the Drug and No-drug groups
shown in Fiq. 1 indicates principally that at all shock inten-
sities for both day 1 and day 5 the Drug group had a signifi-
cantly lower value of average responses than the No-drug group.
Fig. 1 also shows that for the No-drug group there is virtual-
ly no difference in response level for' the first and fifth day
over all shock levels. But., for the Drug group it is seen,
that the response level approaches the No-drug values as a
function of shock levels. . The above findings are statistical-
ly reliable as indicated by a significant Days effect (p<.025)
and a Groups x Days interaction (p<.025).
Further, Fig. 1 shows for the Drug group that at low
shock levels (25-125 mA) the response level was depressed and
tended to remain so even through the fifth day, while at the
higher shock levels by the fifth day the response level in-
creased almost to control values. As will be seen, this
Table 1 - Analysis of variance of responses to varying foot-
shock intensities for Drug and No-drug group (the
jump-flinch test)
Source of Variance df MS F p<
Between Group Variance
G (Groups—Drug vs. No-drug) 1 611.47 8.77 p<.01
S/G " 26 69.69
Within Group Variance
D (Days) 4 . 17.97 3.05 p<.025
GD 4 17.88 3 .04 p<.025
sd/g 104 5.91
T (Trials)
.
9 1.46 1.48 N.S.
GT 9 ,1.05 1.01 N.S.
ST/G 234 1.01
L (Shock levels) 18 317.77 288.9 p<.001
GL 18 1.00 .9 N.S.
SL/G 468 1.05
DT 36 1.00 1.15 N.S.
GDT 36 1.54 1.72 P<-01
SDT/G 936 .87
DL 72 .68 1.66 p< .005
GDL 72 .78 1.90 p<.005
SDL/G 1872 .41
TL 162 .44 1.26 N.S.
GTL 162 .34 1.00 N.S.
STL/ G 4212 .35
DTL 648 .30 .90 N.S.
GDTL 648 .35 1.01 N.S.
5DTL/
G
16848 .33
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Fig. 1. Comparisons of the effect of CDP and no drug on respon-
ses to varying levels of foot shock intensity for the first and
fifth days of testing.
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finding is related to the detection of tolerance effects under
different motivational levels.
Last, a Groups x Days x Trials effect was found to be sig-
nificant (p<.01). It is quite possible that this interaction
was a chance occurrence owing to the large number of inter-
actions that were possible. A graphic representation of these
Groups x Days x Trials variables was found to be exceedingly
complex, and the only discernable trend that could be detected
was that during early trials there was more variance for the
drugged animals for the first few days of testing. Then as
days progressed the variance over trials diminished. For the
non-drugged animals, the proportion of responses over trials
was more stable from day to day.
DISCUSSION
The significant findings in this study were: (a) higher
values of responses for higher levels of foot shock , ( b) over-
all lower response value for CDP treated rats
,
(c) virtually
no change in response values over days for the control rats,
and, (ci) increasing response values over days for the drugged
rats as a function of foot shock intensity. Thus, the data
demonstrated that any attenuation of responding due to general
behavioral depression that occurred with the initial dosing
with CDP had almost disappeared by the fifth day of drug test-
ing when the test utilized higher levels of foot shock. Fur-
ther, it appears as though the presence of tolerance effects
requires comparatively high levels of foot shock.
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Having established that tolerance occurs after repeated
administration of CDP, the next step was to observe the effect
of tolerance to CDP-induced general behavioral depression on
CDP-induced suppression of shock-induced aggression.
EXPERIMENT lb.
The effects of CDP on shock-induced aggression.
The purpose of this experiment was to determine the effects
of CDP on shock-induced aggression. There was a further attempt
to isolate and eliminate the effects of general behavioral de-
pression by repeated testing permitting tolerance to occur.
METHOD
Subj ects
The subjects were 48 Charles River, Sprague-Dawley strain,
male white albino rats, from 80 to 100 days old.
Apparatus
The apparatus for this experiment was the same as for
experiment 1. A cumulative recorder was attached to the fight-
ing response counter to provide a running record of the amount
of fighting for each session.
Procedure
The 48 rats were randomly paired and assigned to four
groups . Each group received 10 consecutive daily tests fol-
lowed by one day of rest and then ten additional test days.
Group 1 (No Drug) received no drug. Ten days of shock-induced
-16-
aggression testing was followed by one rest day and then ten
consecutive days of snock-induced aggression testing still
without drug.
Group 2 (Drug before) received 15 mg/kg i.p. 30 minutes
before each of the shock-induced fighting tests on the first
10 days. After one day of rest, the rats had 10 consecutive
days of shock-induced fighting without receiving drug.
The third group (Drug - no test) received 15 mg/kg CDP
i.p. 30 minutes before each test session during which the
animals were placed in the experimental chamber but received
no shocks. After 10 days of drug and one rest day the animals
had ten days of aggression testing but did not receive drug.
Group 4 (Drug after) was tested using the same fighting
paradigm for 10 days and received 15 mg/kg CDP immediately
after the completion of the shock-induced fighting test.
After one day of rest, this group was subjected to the shock-
induced fighting but received no drug for 10 additional days.
These procedures are summarized in Table 2.
For each fighting test one pair of rats was placed in
the experimental chamber and allowed to move about freely.
After a .few minutes the rats were subjected to repeated 2.0
mA. grid shocks with a duration of 0.5 seconds. Thirty shocks
per minute for 10 minutes (300 shocks) constituted one test-
ing session. The experimenter meanwhile recorded fighting
responses by operating a handswitch. Responses designated as
fighting responses were any aggressive striking or poking by
either rat while it was on its rear limbs in the typical
-17-
Table 2
Procedure for Experiment 2
Stage 1 Stage 2
Group 10 daily tests
of 300 trials each
Rest 10 daily
tests of 300
trials each
Group 1
(No Drug)
SIA* 1 day SIA No drug
Group 2
(Drug before)
SIA + pre-CDP 1 day SIA No drug
Group 3
(Drug - no test
)
CDP 1 day SIA No drug
Group 4
(Drug after)
SIA + post-CDP 1 day SIA No drug
*shock-induced aggression
fighting posture (see Ulrich and Azrin, 1962). A fighting
response was not recorded if the animal made threatening
gestures without making contact, or if the animals stood with
their front paws in contact but were not striking. The ag-
gressive fighting posture was generally easy to determine
since it consisted of quite characteristic behavior. However,
cases did occur when evaluation was more difficult such as
when the animals were standing in the aggressive posture and
were moving their paws but not in the typical aggressive
fashion. Questionable instances such as these were infrequent
and on the whole, inter-rater reliability for judging fight-
ing responses was high (approximately 95%).
Results
The results of the shock-induced fighting test are
reported in Table 3 and illustrated in Fig. 2. Using an
analysis of variance, a comparison was .made among the No-drug
control group , the Drug group which received CDP 30 minutes
before testing , and the group which received 1 5 mg/kg CDP
immediately after testing • The results demonstrate a clearly
significant difference in the amount of fighting during the
first 10 days of testing (p<.001). When multiple comparisons
were made a highly significant difference was found between
the Drug-before group and the average scores of the No-drug
and Drug-after groups (p<.001). A significant difference
was also found between the No-drug and Drug-after group (p<.001
demonstrating that not only did pre-treatment with CDP reduce
-19-
Table 3 - Analyses of. variance of the number of fighting
responses for the no drug control group, drug-
before group, drug-after group, and drug- no test
groups for the first and second ten-day fighting
tests.
Analysis of variance #1 - comparison of no-drug, drug-before,
and drug-after groups for the first 10 days of fighting tests
Source of variance df MS F
G (groups) 2 304226,.1 34.5 PC.001
S/G 15 8827..2
D • (days') 9 4176..9 3.09 p<.005
GD 18 15 70..2 1.2 N.S.
SD/G 135 1354..0
Analysis of variance #2 - comparison of the 4 groups over test
2.
Source of variance df IIS
G
S/G
D
GD
SD/G
3
20
9
27
180
3628.1
9656.9
5122.1
3333.7
1134.8
.37
4.5
2.9
N.S.
p^.001
pc.001
Analysis of variance #3 - within subj ects comparison of the
drug-before group over tests 1 & 2.
Source of variance df MS F
T (first 10 days vs. 2nd
10 days testing) 1 285480.1 24.4 p<.005
ST 5 11685.3
D 9 1404.7 1.02 N.S.
SD 45 1383.6
TD 9 526.5 .5 N.S.
SPD 45 104 7.3
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Fig. 2. The effect of CDP cn shock- i nduced aggression. The mean
number of fighting responses over days of shock- i nduced aggression
testing for control and CDP-treated groups. One group received
only drug administration for 10 days, and was tested on shock-
induced aggression for the first time in Test 2.
fighting but also that treatment with CDP immediately after
the fighting test significantly reduced fighting on subse-
quent days, A Days main effect, indicating a change in the
amount of fighting over the ten days of the first fighting
test, was also highly significant (p<.001). No significant.
Groups x Days interaction effect could be detected suggest-
ing that the change over days was not a function of group.
An examination of the four groups over the second ten
days of fighting tests revealed no difference in the overall
average amount of fighting* The suggestion here is that de-
spite the different treatments administered during the first
ten days, when all groups were tested without drug treatment
during the second ten day test all the groups showed about
the same amount of fighting. However, fighting was found to
change over the second ten day test and this Days effect
(p^.OOl) was matched by a highly significant Groups x Days
interaction (p<.001). These effects imply that the change in
responding over days was not the same for all groups.
A Within Subject's analysis of the fighting responses
for the Drug-before group over both the first and second 10-
day test showed that there was a difference in their amount
of fighting for the first 10 days as compared to the second
(p<.005). This can be seen in Fig. 2. The abrupt rise in
the amount of fighting after the first ten days is clearly
evident
•
The Drug-no test group which received drug without fight-
ing during the first 10 day period showed an unusual peak of
fighting responses when it was tested during the second 10-
day test. This suggested that receiving the 10
-day drug treat-
ment produced responding which was different from that of the
other groups over the second test period. As mentioned pre-
viously an analysis of the four groups over the second 10-day
test showed a significant Groups x Days interaction (p^.001)
indicating a difference between groups over days of testing.
Since the Drug-no test group received fighting tests for the
first time during the second 10-day period, its fighting scores
were compared with those of the control group for the first
10-day test. The. curves of the two groups were virtually over-
lapping •
DISCUSSION
As might have been predicted the group treated with CDP
before testing fought significantly less than either of the
other groups tested over the first ten day period. The signif-
icant Days effect was probably due to the lower levels of
fighting for the first two days of tests. It should be noted
that no significant Groups x Days effect was found, implying
that the three groups varied over the ten days in a similar
way.
The significant increase in fighting during the second
10-day testing period after withdrawal of the drug from the
Drug-before group suggests that no transfer had occurred be-
tween the drug and no-drug state • It seems reasonable that
the drugged rats might have "learned" to suppress fighting in
the first 10-day test, and this would have transferred to
the no-drug state. But this obviously did not occur.
The unexpected significant difference between the No-
drug group and the Drug-after group during the first 10-day
test suggests that CDP administered after the shock-induced
fighting test had some effect on subsequent fighting tests.
The possibility that the drug had an effect on fighting 24
hours after administration seemed unlikely since previous
studies have shown that CDP has a half-life of four to six
hours in the rat and is significantly metabolized within 24
hours after administration (Koechlin , Schwartz , Krol , and
Oberhausli, 1965). An alternate possibility is that the
levels of fear and anxiety remaining after the fighting test
were reduced by the post-test administration of CDP and this
in turn reduced the overall aversiveness of subsequent tests.
This could occur because the reduction of anxiety produced by
the drug injection immediately following the aggression test-
ing became conditioned to the cues of the fighting situation.
Thus, on subsequent days the fighting situation elicited less
fear.
The analysis of the fighting responses of the four group
over the second ten days of testing showed a significant Days
effect and a significant Groups x Days interaction. This
suggests that the change over days was not uniform over group
Looking at Fig. 2 it can be seen that the number of fighting
responses for the Drug-no test group (i.e., the rats that re-
ceived drug without SIA testing during the first 10 days)
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rises to a sharp peak in four days of testing and falls off
steadily from that point. This group alone seems to deviate
from the rather constant level of fighting seen in the other
groups. But the results showed that when this group was com-
pared to the pattern of fighting for the control group during
the first 10 day test, the curves were virtually identical.
Therefore, it would" appear that since the Drug-no fighting
group was not tested -until the second ten days, the change
in that group over days is merely characteristic of a group
run for an initial ten days.
Finally, it was generally observed that even though CDP-
dosed animals did not fight, they actively jumped and scram-
bled about the test chamber in response to the shocks. From
this viewpoint it was quite evident that behavior depression
played, at best, a very minor part in the reduction of fight-
ing by CD P.
The results of the jump-flinch test suggested that toler-
ance to any depressive effect of CDP in the SIA tests would
have occurred after five days of SIA testing. If this reduc-
tion in depressive effect had occurred during SIA testing, a
rise in the level of fighting after approximately five days
of aggression testing would have been expected. However, no
such change was seen during the fighting tests at any point
in the ten day sequence of drug testing. On the other hand,
the absence of any tolerance effect might have been due to
the fact that 2.0 mA of electric current used in the fighting
tests brought about extremely vigorous behavior on the part
of the subjects, so that any CDP-induced depressive effect
was not great enough to be detected behaviorally . ' Consequent-
ly, neither the depressive effect of CDP nor the tolerance to
it could be observed.
In summary, this experiment attempted to eliminate CDP-
induced behavioral depression by repeated administration of
the drug in the expectation that tolerance to the depressive
effect would occur. The results point to the conclusions that
either there was no depressive effect to begin with, or the
depressive effect and tolerance to it were obscured by the
motivational features of the fighting test.
The next experiments attempted to evaluate the possibil-
ity of antagonizing the depressive effect of CDP with the
stimulant drug, caffeine. First, the effects of caffeine and
CDP alone and in combination were evaluated in a spontaneous
activity test. Then the drugs were evaluated in shock-induced
fighting tests.
PART II.
The interactive effects of caffeine and CDP
It was suggested earlier that one way to eliminate a
depressive effect of CDP was to administer concomitantly a
CNS stimulant, such as caffeine. If behavioral depression
is at least partly responsible for the CDP-induced suppres-
sion of fighting, and if the depression were counteracted by
the stimulant effect of caffeine, there should be an increase
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in fighting responses in pairs of rats treated with both
drugs
•
However, a recent study by Beer et al. (1972) showed that
caffeine as. well as the other methylxanthines has a very sig-
nificant anti-anxiety effect. They argued that this effect"
is related to the interference of cyclic AMP phosphodiesterase
activity in the brain. Their argument was based on the observa-
tion that when the compound SQ 20, 009 1 , a potent inhibitor
of phosphodiesterase, was given to rats, cats, and monkeys it
released behavior that was suppressed by punishment in a way
similar to that after administering CDP and diazepam, both of
which also are phosphodiesterase inhibitors. Cyclic AMP phos-
phodiesterase is an enzyme that regulates brain levels of
cyclic AMP but it is not known precisely how this latter sub-
stance is related to behavior except that it acts in an inter-
mediate step between presynaptic exocytosis of transmitter
substance and the resultant postsynaptic neural response.
While it was pointed out previously that the depression
of spontaneous activity by CDP is not of much value in assess-
ing the role of depression by CDP under different motivation-
al states, i.e., during shock-induced fighting, it would be
of value to show that while caffeine would reverse CDP-induced
depression of spontaneous activity, it would potentiate CDP-
induced suppression of fighting. This would be of value because
1 . l-ethyl-4 ( isopropylidine-hydrazino ) -IH-pyrazolo ( 3 , -4-b)
pyridine-5-carboxylic acid, ethyl ester, hydrochloride
it suggests that the anti-aggressive properties of CDP are
not due to its depressant property but rather to the proper-
ty it has in common with the methylxanthines which are CMS
stimulants, namely inhibiting phosphodiesterase activity.
This argument, however, does not rule out the possibility
that some other unknown property held in common by those
substances may be responsible for any anti-aggressive effects
that may be found, but it seems to vitiate the argument that
the sedative action of CDP is largely responsible for its
anti-aggressive effects
•
it would also be of value to show that while caffeine in
the experiments by Beer et al. (1972) released behavior that
was suppressed by punishment, it would also suppress behavior
that was elicited by punishment, such as shock-induced fight-
ing. This would demonstrate that the stimulant effect of
caffeine was not primarily responsible for the release of
punishment-suppressed behavior, but rather that the general
motivational properties of punishment are diminished by caf-
feine.
To study the effect of caffeine on CDP-induced behavior-
al depression, two more experiments were done • The first
experiment showed that caffeine reversed the CDP-induced de-
pression of spontaneous activity, and the second demonstrated
that caffeine potentiated CDP-induced suppression of shock-
induced fighting.
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EXPERIMENT Ila.
The effect of caffeine and CDP on spontaneous activity.
The purposed of this experiment was to determine the
extent to which caffeine counteracted the CDP-induced sup-
pression of spontaneous activity. A Within Subjects design
was used. In this way the effects of caffeine and CDP ad-
ministered singly as well as concomitantly were assessed for
each animal
•
Since both drugs are rapidly metabolized, no cumulative
effect is likely from one day to the next. However, to fur-
ther reduce the possibility of confounding the data with
cumulative drug effects, testing was done on alternate days
to make doubly sure that all drugs were completely metabolized.
It will be seen that in the shock-induced fighting tests in
Experiment lib the subjects were tested on successive days.
This was done because (1) pilot studies showed that rest days
result in a decrease in fighting activity on the following .
day while daily testing results in stable fighting rates; and
(2) the responding to the high shock level in fighting tests
are probably not as likely to be affected by slight residual
amounts of unmetabolized drugs.
METHOD
Subjects
The subjects were 15 Charles River, Sprague-Dawley strain,
male white rats, approximately 100 days old when the tests
started.
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Apparatus
The apparatus for this experiment was a cylinder 62 cm.
in diameter and 42 cm. deep with a mesh floor (Lehigh Valley
activity box, model #145-03). Counters provided a record of
the animal's activity as it interrupted light beams that were
detected by photocells located along the perimeter of the
cage. The box was kept in a quiet, darkened room away from
the recording and programming apparatus.
Procedure
Each animal received one of the four treatments each day
for four days. One rest day was allowed between each test
day in order, as was mentioned earlier, to make doubly sure
that there was complete metabolism of the drugs. The treat-
ments were randomly ordered and assigned to give each rat all
of the treatments without repetition of treatment . The four
treatments were: (1) no drug, (2) 15 mg/kg CDP i..p., (3) 50
mg/kg caffeine benzoate i.p., and (4) 15 mg/kg CDP plus 50
mg/kg caffeine benzoate i.p. Thirty minutes after receiving
the appropriate treatment the subject was placed in the activ-
ity box and allowed to move about freely for 20 minutes.
Results
The principal results of the spontaneous activity test
are shown in Figure 3. A Wilcoxon Matched-Pairs Signed-Ranks
Test was used to evaluate the data. A significant difference
between the No-drug control group and CDP-treated group (p<.01)
shows the typical depression of behavior after CDP administration.
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Although treatment with caffeine generally increased the
spontaneous activity, a Wilcoxon Test did not indicate a
significant difference between the Caffeine group and the No-
drug control group. However, the more sensitive correlated
t-test did prove significant (p<.05).
Administered in combination, the two drugs appeared to
have a antagonistic effect. The Wilcoxon test indicated that
the activity under both drugs was greater than that of the
CDP-alone group (p<.01) and significantly less than the Caf-
feine-alone group (pv.01). The combined drug score was also
found to be significantly lower than control levels (p<.01), .
but the combined drug score was almost exactly midway between
the CDP and "the caffeine score. The difference between the
combined drug score and the CDP and Caffeine score was 442
and 474 activity counts respectively.
DISCUSSION
The results of experiment Ila clearly demonstrate that
treatment with CDP and caffeine, a CNS stimulant, have antagon-
istic effects upon spontaneous activity. V/hile CDP was seen
to severely depress spontaneous activity, caffeine significant-
ly increased it. Combining 15 mg/kg CDP with 50 mg/kg caffeine
did not restore activity to the no-drug control level. Rather
it produced an activity score almost exactly mid-way between
the scores of each drug alone. It seems probable that with
manipulation of dose size a complete cancelling effect could
be achieved resulting in a combined drug activity score equal
to that of control treatment. VJhile this result might be
desirable, it is not a primary concern of this study. More
importantly these results clearly show that CDP and caffeine
have an antagonistic effect on spontaneous activity.
EXPERIMENT lib.
The effect of CDP and caffeine on shock-induced fighting.
The purpose of this experiment was to determine if caf-
feine will increase the suppression of shock-induced fighting
when administered with CDP. A Within Subjects (pairs) design
was used as in Experiment Ila.
METHOD
Subjects
The subjects of this experiment were 14 of 15 subjects
used in Experiment Ila. Pairs were formed on the basis of
the effectiveness of the drugs for each subject as measured
by the subject's spontaneous activity under drug and control
conditions.. A measure of drug effectiveness which is called
the drug effectiveness index (DEI) was constructed as follows
The difference between the no-drug control score (conditon A)
and the activity score of the animal after treatment with CDP
(condition B) represents the effectiveness of the CDP treat-
ment. Similarly the efficacy of the caffeine treatment (con-
dition C) was determined by finding the difference between
the animal's no-drug control score (A) and the activity score
recorded while under the influence of caffeine. The sum of
these two scores (A-B) + (C-A) gives an indication of the
effectiveness of CDP and caffeine for depression and stimula-
tion of spontaneous activity respectively.
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Ideally, with concurrent treatment with both drugs (con-
dition D) caffeine should counteract the effect of CDP on
spontaneous activity, making the difference between the control
activity score (A) and the double drug score (D) very small.
Because the sum of the first two differences tends to be
large while the combined drug effect (A-D) ideally should be
small, the former constitues the numerator of the index while
the latter, to increase the value of the index, is placed in
the denominator.
Thus :
(1) (A-B) + (C-A)
(A-D)
Formula (1) can be simplified to:
(2) (C-B)
(A-D)
Thus DEI = C-B
A-D
If the score for the combined drug effect (D) was great-
er than the control score (A), the denominator was arbitrarily
set at 1.00 • This was done to avoid a negative score in the
denominator and thus a negative DEI, A negative DEI would be
misleading because it would suggest that one or both drugs
were not effective in the expected way. If, for example,
caffeine more than compensated for the CDP effect the D score
could be higher than the A score. Thus making A-D negative,
yet the drugs would have had their expected effects. The rat
with the lowest DEI was eliminated, thus providing 14 rats
for 7 pairs.
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Apparatus
The apparatus for this experiment was the same as for
experiment lb. Again the experimenter activated a counter
and a cumulative recorder to provide a record of the number
of fighting responses within each session.
Procedure
Each of the seven pairs was subjected to the fighting
paradigm used in experiment lb for three days in order to
determine the baseline of fighting'. Each pair then received
a random sequence of four treatments, one treatment each day
over four consecutive days • At . the completion of the four
day treatment seauence , a second four day sequence of treat-
ments was given using a different order of drug administration.
The four treatments used were: no drug, 15 mg/kg CDP* i*p«
,
50 mg/kg caffeine benzoate i.p«, and 15 mg/kg CDP plus 50
mg/kg caffeine benzoate i.p. All drug treatments were admin-
istered 30 minutes before SIA testing by another experimenter.
A double-blind technique was used; the experimenter recording
the fighting did not know the drug treatment used for any pair.
Results
A Within Subjects analysis of variance. was done on the
fighting scores for each pair of animals under the four treat-
ments. A nonsignificant Days effect suggests that each drug
had a similar effect regardless of the amount of previous
testing or its relative position in the random sequence.
Despite the use of a highly conservative test of significance
a highly significant Treatment effect was found (p<.005) indi
eating that there was a difference in the amount of fighting
after the various treatments. Further analysis of the Treat-
ments effect using the Newman-Keul 1 s test (Winer, 1962) re-
vealed that the CDP treatment (B), the caffeine treatment (C)
and the combined drug- treatment (D) were each found to be
different from the Mo-drug controls (p^.01). The results of
the Newman-Keul 1 s test are shown- in Table 4, and Fig; 4 clear
ly illustrates these differences. The figure shows, as well,
the difference betv/een the effects of combined drug treatment
with the effects of CDP and caffeine given alone. (p<.01).
Comparison of the CDP treatment scores and those of the caf-
feine treatment revealed no significant difference in the
amount of suppression of fighting between these two treatment
Further examination of the data represented in Fig. 4
shows that with administration of caffeine there v/as a 34%
,
reduction in the number of fighting responses. After treat-
ment with CDP, fighting was reduced by 41%. The combined
drug treatment produced a nearly additive effect by reducing
fighting by 69%.
1. Assuming non-additivity and heterogeneity of variance and
covariances, the F score was assessed against the F re-
ouired for significance on 1 and n-1 degrees of freedom.
(Myers, J. , Fundamentals of Experimental Design, Allyn
and Bacon, Inc., 1971, p. 162.
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Table 4 - Hewman-Keul ' s analysis of the difference in amount
of fighting for all subjects under four conditions
•
(1) no drug (A), (2) 15 mg/kg CDP (B), (3) 50 mg/kg
caffeine (C), (4) caffeine and CDP (D)
D B C A
Totals 716 1275 1425 2155
D 716 599* 709* 1439*
B
.
1275 150 880*
C 142 5 730*
A 2155
q. 99 (r, 18) 4.07 4.70 5.09
T nHS qres4 . 99 (r,18) 382.17 • 441.33 477.95
* significant (p< .01
)
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• DISCUSSION
The results of experiment lib clearly demonstrated again
the effectiveness of CDP in reducing shock-induced fighting
In rats. Overall, fighting after treatment with CDP was re-
duced by 41%. An equally significant anti-aggressive effect
of the caffeine-alone treatment was found, although fighting
was reduced by only 34%. Also, a real difference between
each of these single treatments and the combined drug treat-
ment was found. In fact, the combined drug effect was almost
equal to the sum of each of the two individual effects. Con-
trary to the antagonistic action of caffeine on CDP's depress-
ive effect on spontaneous activity shown in experiment II a
,
the two drugs have a similar effect on the suppression of
shock-induced fighting
.
These findings provide the strongest argument to date
against the notion that the depressive effect of CDP is
responsible for the suppression of aggression in rats. The
data clearly showed that caffeine did antagonize the depress-
ive effects of CDP in the spontaneous activity test. If the
suppression of fighting with CDP were due to general depress-
ion, and if caffeine had the same effect of antagonizing
depression during aggression testing, then CDP plus caffeine
should have produced more rather than less fighting than that
found in rats treated with CDP alone. If caffeine and CDP
both had only a suppressing effect on aggression, one might
assume that the two effects would be completely additive. On
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the other hand, if CDP induced depression accounted for part
of the reduction of fighting and if caffeine antagonized this
depression, it could account for the difference between the
combined effect of the drugs (69%) and the sum of the separate
effects (75%), a difference of only 6%. Even if the differ-
ence of 6% only represents half of the effects of depression,
the role of depression is still quite small. The data of
experiment la likewise suggest that even if the suppression
of aggression by CDP were due at least in part to a general
depressive effect, the depressant effects of the drug would
probably be minimal after five days of drug administration.
To explain the anti-aggression effects of CDP in neuro-
chemical terms the following facts should be considered,
i
First , the benzodiazepines are effective in releasing behav-
ior that is suppressed by punishment (Wise, et al , 1972 ; Beer
et al , 19 72; Margules and Stein, 1968 ; F eldman and Green , 1967 )
.
The present study shows they are equally effective in sup-
pressing irritable aggression, i.e. , shock-induced fighting.
Second, oxazepam, a benzodiazepine, reduced the turnover
rates of 5HT (Wise et al, 1972), thus presumably blocking the
brain stem 5HT mechanisms associated with punishment. Also
the time course of the change in 5HT turnover correlated well
with the time course of the anti-anxiety effects of oxazepam.
Third, the benzodiazepines as well as caffeine, theophylline,
and 3Q 20, 009 are phosphodiesterase inhibitors and these also
are anxiety suppressing compounds (Beer et al, 1972). The
results of the present study also support this view.
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The question that remains is whether blocking 5HT turn-
over has anti-anxiety effects under some circumstances while
phosphodiesterase inhibition is responsible for anti-anxiety
effects under other circumstances. One possible explanation
is that phosphodiesterase inhibition is indirectly responsi-
ble for brain 5HT depletion which could have the same effect
as a mechanism that would lead to a reduction of 5HT turnover.
An explanation might be as follows. It is known that the
level of cAMP represents the balance between the activities
of two opposing enzymes
,
adenyl cyclase and phosphodiesterase*
The former catalyzes the conversion of adenosine triphosphate
(ATP) to cAMP, the latter catalyzes the hydrolysis of cAMP to
5' AMP (Robinson, Butcher and Sutherland, 1972). Thus, the in-
hibition of phosphodiesterase would presumably lead to an in-
crease of cAMP levels. Since cAMP is considered to be a second
messenger in synaptic transmission involving norepmeprine (NE)
(Robinson et al, 1972), a high build-up of cAMP might then by
a negative feedback mechanism, reduce or block the release of
NE from presynaptic terminals and lead to higher brain levels
of this amine. , Everett and Borcherding, (1970) have shown
that injections of L-Dopa not only produce a rise in brain
levels of dopamine but also a significant drop in brain levels
of 5HT and increase urine levels of the serotonin metabolite
5-HIAA. This suggests that a rise in dopamine leads to a loss
of vesticular 5HT and its deamination by MAO. It follows that
the presynaptic build-up and increased brain levels of cate-
cholamines by a phosphodiesterase inhibitor might ultimately
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lead to a depletion of brain 5HT. Thus, it seems that while
CDP blocks serotonergic transmission directly as suggested by
Wise et al (1972) the xanthines might have the same effect
by lowering the amount of available 5HT. However , the find-
ings by Connor et al (1970) that the lowering of brain 5HT
with pCPA had no effect on shock-induced fighting cannot pre-
sently be explained by this argument. Hopefully, future
research will resolve these difficulties.
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